Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. | Nat Commun | 2022 | 36396935 | PubTator, text mining | PubMed |
| Induced pluripotent stem cells and cerebral organoids from the critically endangered Sumatran rhinoceros. | iScience | 2022 | 36388963 | PubTator, text mining | PubMed |
| In vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesis. | Cell Rep Med | 2022 | 36384103 | PubTator, text mining | PubMed |
| Canine induced pluripotent stem cells efficiently differentiate into definitive endoderm in 3D cell culture conditions using high-dose activin A. | Regen Ther | 2022 | 36382137 | PubTator, text mining | PubMed |
| Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoid. | Nat Commun | 2022 | 36379937 | PubTator, text mining | PubMed |
| Synthetic gene circuits for cell state detection and protein tuning in human pluripotent stem cells. | Mol Syst Biol | 2022 | 36366891 | PubTator, text mining | PubMed |
| Mechanistic Contributions of lncRNAs to Cellular Signaling Pathways Crucial to the Lifecycle of Human Papillomaviruses. | Viruses | 2022 | 36366537 | PubTator, text mining | PubMed |
| Capability of Human Dendritic Cells Pulsed with Autologous Induced Pluripotent Stem Cell Lysate to Induce Cytotoxic T Lymphocytes against HLA-A33-Matched Cancer Cells. | Int J Mol Sci | 2022 | 36361783 | PubTator, text mining | PubMed |
| Prognostic Analysis of Human Pluripotent Stem Cells Based on Their Morphological Portrait and Expression of Pluripotent Markers. | Int J Mol Sci | 2022 | 36361693 | PubTator, text mining | PubMed |
| Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia. | Cells | 2022 | 36359747 | PubTator, text mining | PubMed |
| Molecular Analysis of Pancreatic Cyst Fluid for the Management of Intraductal Papillary Mucinous Neoplasms. | Diagnostics (Basel) | 2022 | 36359417 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36358885 | PubTator, text mining | PubMed |
| Prostate Cancer Stem Cells: The Role of CD133. | Cancers (Basel) | 2022 | 36358865 | PubTator, text mining | PubMed |
| Development of extrahepatic bile ducts and mechanisms of tumorigenesis: Lessons from mouse models. | Pathol Int | 2022 | 36349994 | PubTator, text mining | PubMed |
| Downstream bioprocessing of human pluripotent stem cell-derived therapeutics. | Eng Life Sci | 2022 | 36348655 | PubTator, text mining | PubMed |
| Spatially resolved gene regulatory and disease-related vulnerability map of the adult Macaque cortex. | Nat Commun | 2022 | 36347848 | PubTator, text mining | PubMed |
| CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. | Cancer Cell Int | 2022 | 36344976 | PubTator, text mining | PubMed |
| An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. | Commun Biol | 2022 | 36344664 | PubTator, text mining | PubMed |
| Generation and characterization of a human induced pluripotent stem cell (iPSC) line from a patient with congenital heart disease (CHD). | Stem Cell Res | 2022 | 36343514 | PubTator, text mining | PubMed |
| Contribution of TWIST1-EVX1 Axis in Invasiveness of Esophageal Squamous Cell Carcinoma; a Functional Study. | Iran J Biotechnol | 2022 | 36337061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=41